<DOC>
	<DOCNO>NCT02854449</DOCNO>
	<brief_summary>This study follow-up different immune cell population blood , high dose radiation therapy give new information efficacy Local Hypofractionated Radiotherapy rationale adjuvant immunotherapy .</brief_summary>
	<brief_title>Tumor Response Hypofractionated Radiotherapy</brief_title>
	<detailed_description>- Patient information collection sign informed consent form - Clinical data collection - Blood sample 5 mL : 1. registration , prior first fraction radiotherapy 2. radiotherapy session 3. one month , 3 month last radiotherapy session - Storage blood sample ambient temperature - Transportation sample Institute Biology Lille ( IBL ) - CNRS UMR8161 analysis - Destruction sample end analysis</detailed_description>
	<criteria>Patient require hypofractionated irradiation ; pathologically confirm Unspecified Adult Solid Tumor Age ≥ 18 year old KPS≥70 Signed write informed consent . Patient treat chemotherapy , target immunotherapy within 21 day first sample , Pregnant breastfeed woman , Patient guardianship tutorship .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Immune Marker</keyword>
	<keyword>Immunologic Marker</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Dose Hypofractionation</keyword>
</DOC>